Immune vulnerability of infants to tuberculosis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Vanden Driessche, Koen ^a,b   Persson, Alexander ^a   Marais, Ben J ^c   Fink, Pamela J ^d   Urdahl, Kevin B ^d,e,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WASHINGTON   (United States)

^e SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; B7 ANTIGEN; BETA DEFENSIN 2; CD40 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; STAT1 PROTEIN; IMMUNOLOGIC FACTOR; INTERLEUKIN 1; TUBERCULOSTATIC AGENT;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; BACTERIAL COLONIZATION; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; IMMUNOREGULATION; INFANT DISEASE; INFECTION SENSITIVITY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TUBERCULOUS MENINGITIS; ADULT; AGE; BIOSYNTHESIS; CHILD; DISEASE PREDISPOSITION; DRUG EFFECT; IMMUNOLOGY; INFANT; PATHOGENICITY; PATHOPHYSIOLOGY; TUBERCULOSIS; DRUG EFFECTS;

ADULT; AGE FACTORS; ANTITUBERCULAR AGENTS; CHILD; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INFANT; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-12; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84878637710     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/781320     Document Type: Review

References (228)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M. C., Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. The Journal of the American Medical Association 1999 282 7 677 686 2-s2.0-0033581124 10.1001/jama.282.7.677 (Pubitemid 29384157)
2. Nunn P., Williams B., Floyd K., Dye C., Elzinga G., Raviglione M., Tuberculosis control in the era of HIV. Nature Reviews Immunology 2005 5 10 819 826 2-s2.0-25844434417 10.1038/nri1704 (Pubitemid 41400855)
3. Small P. M., Fujiwara P. I., Management of tuberculosis in the United States. The New England Journal of Medicine 2001 345 3 189 200 2-s2.0-0035913260 10.1056/NEJM200107193450307 (Pubitemid 32662129)
4. Lillebaek T., Dirksen A., Baess I., Strunge B., Thomsen V. O., Andersen A. B., Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. Journal of Infectious Diseases 2002 185 3 401 404 2-s2.0-0036467798 10.1086/338342 (Pubitemid 34107256)
5. Van Rie A., Warren R., Richardson M., Victor T. C., Robert P G., Enarson D. A., Beyers N., van Helden P. D., Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. The New England Journal of Medicine 1999 341 16 1174 1179 2-s2.0-0344289512 10.1056/NEJM199910143411602 (Pubitemid 29480655)
6. Charalambous S., Grant A. D., Moloi V., Warren R., Day J. H., van Helden P., Hayes R. J., Fielding K. L., de Cock K. M., Chaisson R. E., Churchyard G. J., Contribution of reinfection to recurrent tuberculosis in South African gold miners. International Journal of Tuberculosis and Lung Disease 2008 12 8 942 948 2-s2.0-49149091213
7. World Health Organization, Global Tuberculosis Report 2012 2012 Lyon, France World Health Organization
8. Perez-Velez C. M., Marais B. J., Tuberculosis in children. The New England Journal of Medicine 2012 367 4 348 361 10.1056/NEJMra1008049
9. UNICEF, Committing to child survival: a promise renewed. Progress Report 2012 2012
10. Heyns L., Gie R. P., Goussard P., Beyers N., Warren R. M., Marais B. J., Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: a risk in tuberculosis-endemic areas. Acta Paediatrica 2006 95 5 535 539 2-s2.0-33646903340 10.1080/08035250600636560 (Pubitemid 43791574)
11. Marais B. J., Gie R. P., Schaaf H. S., Hesseling A. C., Obihara C. C., Starke J. J., Enarson D. A., Donald P. R., Beyers N., The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. International Journal of Tuberculosis and Lung Disease 2004 8 4 392 402 2-s2.0-2442484961 (Pubitemid 38624845)
12. Lincoln E. M., Course and prognosis of tuberculosis in children. The American Journal of Medicine 1950 9 5 623 632 2-s2.0-0001161280
13. Schaaf H. S., Collins A., Bekker A., Davies P. D., Tuberculosis at extremes of age. Respirology 2010 15 5 747 763 10.1111/j.1440-1843.2010.01784.x
14. Goussard P., Gie R. P., Kling S., Schaaf H. S., Kritzinger F., Andronikou S., Beyers N., Rossouw G. J., The outcome of infants younger than 6 months requiring ventilation for pneumonia caused by Mycobacterium tuberculosis. Pediatric Pulmonology 2008 43 5 505 510 2-s2.0-43249094265 10.1002/ppul.20812 (Pubitemid 351657319)
15. Seddon J. A., Visser D. H., Bartens M., Jordaan A. M., Victor T. C., van Furth A. M., Schoeman J. F., Schaaf H. S., Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatric Infectious Disease Journal 2012 31 7 711 716 10.1097/INF.0b013e318253acf8
16. Sharma S. K., Mohan A., Sharma A., Challenges in the diagnosis & treatment of miliary tuberculosis. Indian Journal of Medical Research 2012 135 5 703 730
17. Donald P. R., Schaaf H. S., Schoeman J. F., Tuberculous meningitis and miliary tuberculosis: the rich focus revisited. Journal of Infection 2005 50 3 193 195 2-s2.0-14944383274 10.1016/j.jinf.2004.02.010 (Pubitemid 40361529)
18. van Well G. T. J., Paes B. F., Terwee C. B., Springer P., Roord J. J., Donald P. R., van Furth A. M., Schoeman J. F., Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the Western cape of South Africa. Pediatrics 2009 123 1 e1 e8 2-s2.0-63849291316 10.1542/peds.2008-1353
19. Thwaites G. E., Hien T. T., Tuberculous meningitis: many questions, too few answers. The Lancet Neurology 2005 4 3 160 170 2-s2.0-13944280686 10.1016/S1474-4422(05)01013-6 (Pubitemid 40269146)
20. Cooper A. M., Cell-mediated immune responses in tuberculosis. Annual Review of Immunology 2009 27 393 422 2-s2.0-67650932256 10.1146/annurev.immunol. 021908.132703
21. Ramakrishnan L., Revisiting the role of the granuloma in tuberculosis. Nature Reviews Immunology 2012 12 5 352 366
22. Remington J. S., Klein J. O., Wilson C. B., Nizet V., Maldonado Y. A., Infectious Diseases of the Fetus and Newborn Infant 2011 Philadelphia, Pa, USA Elsevier Saunders
23. + T cell-mediated suppression by dendritic cells. Science 2003 299 5609 1033 1036 2-s2.0-0037436119 10.1126/science.1078231 (Pubitemid 36222922)
24. Firth M. A., Shewen P. E., Hodgins D. C., Passive and active components of neonatal innate immune defenses. Animal Health Research Reviews 2005 6 2 143 158 2-s2.0-33646170919 10.1079/AHR2005107
25. Marodi L., Innate cellular immune responses in newborns. Clinical Immunology 2006 118 2-3 137 144 10.1016/j.clim.2005.10.012 (Pubitemid 43199650)
26. Tremaroli V., Backhed F., Functional interactions between the gut microbiota and host metabolism. Nature 2012 489 7415 242 249 10.1038/nature11552
27. Costello E. K., Stagaman K., Dethlefsen L., Bohannan B. J., Relman D. A., The application of ecological theory toward an understanding of the human microbiome. Science 2012 336 6086 1255 1262 10.1126/science.1224203
28. Nicholson J. K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S., Host-gut microbiota metabolic interactions. Science 2012 336 6086 1262 1267 10.1126/science.1223813
29. Johnson C. L., Versalovic J., The human microbiome and its potential importance to pediatrics. Pediatrics 2012 129 5 950 960 10.1542/peds.2011-2736
30. Frei R., Lauener R. P., Crameri R., O'Mahony L., Microbiota and dietary interactions: an update to the hygiene hypothesis? Allergy 2012 67 4 451 461 10.1111/j.1398-9995.2011.02783.x
31. Riley R. L., Mills C. C., O'Grady F., Sultan L. U., Wittstadt F., Shivpuri D. N., Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. The American Review of Respiratory Disease 1962 85 511 525 2-s2.0-0005026196
32. Kang P. B., Azad A. K., Torrelles J. B., Kaufman T. M., Beharka A., Tibesar E., DesJardin L. E., Schlesinger L. S., The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. Journal of Experimental Medicine 2005 202 7 987 999 2-s2.0-25844508945 10.1084/jem.20051239 (Pubitemid 41396898)
33. Armstrong J. A., D'Arcy Hart P., Phagosome lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. Journal of Experimental Medicine 1975 142 1 1 16 2-s2.0-0016742008
34. Hayakawa E., Tokumasu F., Nardone G. A., Jin A. J., Hackley V. A., Dvorak J. A., A Mycobacterium tuberculosis -derived lipid inhibits membrane fusion by modulating lipid membrane domains. Biophysical Journal 2007 93 11 4018 4030 2-s2.0-36849095525 10.1529/biophysj.107.104075 (Pubitemid 350223817)
35. Perskvist N., Roberg K., Kulyté A., Stendahl O., Rab5a GTPase regulates fusion between pathogen-containing phagosomes and cytoplasmic organelles in human neutrophils. Journal of Cell Science 2002 115 6 1321 1330 2-s2.0-0037087512 (Pubitemid 34272496)
36. van der Wel N., Hava D., Houben D., Fluitsma D., van Zon M., Pierson J., Brenner M., Peters P. J., M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007 129 7 1287 1298 2-s2.0-34250716965 10.1016/j.cell.2007.05.059 (Pubitemid 46962098)
37. Simeone R., Bobard A., Lippmann J., Bitter W., Majlessi L., Brosch R., Enninga J., Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLOS Pathogens 2012 8 2 e1002507 10.1371/journal.ppat. 1002507
38. Flynn J. L., Chan J., Lin P. L., Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunology 2011 4 3 271 278 2-s2.0-79955111092 10.1038/mi.2011.14
39. Wolf A. J., Linas B., Trevejo-Nuñez G. J., Kincaid E., Tamura T., Takatsu K., Ernst J. D., Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. Journal of Immunology 2007 179 4 2509 2519 2-s2.0-34848910546
40. Weinberg A. G., Rosenfeld C. R., Manroe B. L., Browne R., Neonatal blood cell count in health and disease. II. Values for lymphocytes, monocytes, and eosinophils. Journal of Pediatrics 1985 106 3 462 466 2-s2.0-0021957508 (Pubitemid 15140656)
41. English B. K., Hammond W. P., Lewis D. B., Brown C. B., Wilson C. B., Decreased granulocyte-macrophage colony-stimulating factor production by human neonatal blood mononuclear cells and T cells. Pediatric Research 1992 31 3 211 216 2-s2.0-0026524848
42. Alenghat E., Esterly J. R., Alveolar macrophages in perinatal infants. Pediatrics 1984 74 2 221 223 2-s2.0-0021203789 (Pubitemid 14054162)
43. Jacobs R. F., Wilson C. B., Smith A. L., Haas J. E., Age-dependent effects of aminobutyryl muramyl dipeptide on alveolar macrophage function in infant and adult Macaca monkeys. The American Review of Respiratory Disease 1983 128 5 862 867 2-s2.0-0021033093 (Pubitemid 14231339)
44. Blahnik M. J., Ramanathan R., Riley C. R., Minoo P., Lipopolysaccharide- induced tumor necrosis factor- α and IL-10 production by lung macrophages from preterm and term neonates. Pediatric Research 2001 50 6 726 731 2-s2.0-0035196535 (Pubitemid 33121642)
45. Raghunathan R., Miller M. E., Everett S., Leake R. D., Phagocyte chemotaxis in the perinatal period. Journal of Clinical Immunology 1982 2 3 242 245 2-s2.0-0020329345 (Pubitemid 12053310)
46. Becker I. D., Robinson O. M., Bazan T. S., Bactericidal capacity of newborn phagocytes against group B β -hemolytic streptococci. Infection and Immunity 1981 34 2 535 539 2-s2.0-0019769451 (Pubitemid 12117557)
47. Weston W. L., Carson B. S., Barkin R. M., Slater G. D., Dustin R. D., Hecht S. K., Monocyte-macrophage function in the newborn. The American Journal of Diseases of Children 1977 131 11 1241 1242
48. Kretschmer R. R., Stewardson P. B., Papierniak C. K., Gotoff S. P., Chemotactic and bactericidal capacities of human newborn monocytes. Journal of Immunology 1976 117 4 1303 1307 2-s2.0-0017110235
49. Orlowski J. P., Sieger L., Anthony B. F., Bactericidal capacity of monocytes of newborn infants. Journal of Pediatrics 1976 89 5 797 801 2-s2.0-0017132950
50. Hawes C. S., Kemp A. S., Jones W. R., In vitro parameters of cell-mediated immunity in the human neonate. Clinical Immunology and Immunopathology 1980 17 4 530 536 2-s2.0-0019156967 (Pubitemid 11238566)
51. Speer C. P., Gahr M., Wieland M., Eber S., Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatric Research 1988 24 2 213 216 2-s2.0-0023802007
52. Conly M. E., Speert D. P., Human neonatal monocyte-derived macrophages and neutrophils exhibit normal nonopsonic and opsonic receptor-mediated phagocytosis and superoxide anion production. Biology of the Neonate 1991 60 6 361 366 2-s2.0-0026355335
53. D'Ambola J. B., Sherman M. P., Tashkin D. P., Gong H., Human and rabbit newborn lung macrophages have reduced anti-candida activity. Pediatric Research 1988 24 3 285 290 2-s2.0-0023713812
54. Bellanti J. A., Nerurkar L. S., Zeligs B. J., Host defenses in the fetus and neonate: studies of the alveolar macrophage during maturation. Pediatrics 1979 64, part 2 5 726 739 2-s2.0-0018613120 (Pubitemid 10195713)
55. Kurland G., Cheung A. T. W., Miller M. E., Ayin S. A., Cho M. M., Ford E. W., The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys. Pediatric Research 1988 23 3 293 297 2-s2.0-0023874056 (Pubitemid 18079927)
56. Maródi L., Deficient interferon- γ receptor-mediated signaling in neonatal macrophages. Acta Paediatrica 2002 91 438 117 119 2-s2.0-0036429764 (Pubitemid 35347071)
57. + T cells during Mycobacterium tuberculosis infection. Journal of Immunology 2011 186 12 7110 7119 2-s2.0-79959564980 10.4049/jimmunol.1100001
58. Doru D., Kiper N., Özçelik U., Yalçin E., Tezcan I., Tuberculosis in children with congenital immunodeficiency syndromes. Tuberkuloz ve Toraks 2010 58 1 59 63 2-s2.0-77951674522
59. Lee P. P. W., Chan K. W., Jiang L., Chen T., Li C., Lee T. L., Mak P. H. S., Fok S. F. S., Yang X., Lau Y. L., Susceptibility to mycobacterial infections in children with x-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatric Infectious Disease Journal 2008 27 3 224 230 2-s2.0-44949109341 10.1097/INF. 0b013e31815b494c
60. Movahedi M., Aghamohammadi A., Farhoudi A., Moin M., Pourpak Z., Gharagozlou M., Mansouri D., Jandaghi A. B., Shahnavaz N., Rezaei N., Abolmaali K., Arasi S. A., Bakhshaei J., Vaziri M., Respiratory manifestations of chronic granulomatous disease; a clinical survey of patients from Iranian primary immunodeficiency registry. Iranian Journal of Allergy, Asthma and Immunology 2003 2 1 45 51
61. Reichenbach J., Rosenzweig S., Döffinger R., Dupuis S., Holland S. M., Casanova J. L., Mycobacterial diseases in primary immunodeficiencies. Current Opinion in Allergy and Clinical Immunology 2001 1 6 503 511 2-s2.0-0035750449
62. Yang C. T., Cambier C. J., Davis J. M., Hall C. J., Crosier P. S., Ramakrishnan L., Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages. Cell Host and Microbe 2012 12 3 301 312 10.1016/j.chom.2012.07.009
63. Blomgran R., Desvignes L., Briken V., Ernst J. D., Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host and Microbe 2012 11 1 81 90 10.1016/j.chom.2011.11. 012
64. Chirico G., Marconi M., de Amici M., Gasparoni A., Mingrat G., Chiara A., Rondini G., Ugazio A. G., Deficiency of neutrophil bactericidal activity in term and preterm infants. A longitudinal study. Biology of the Neonate 1985 47 3 125 129 2-s2.0-0021992026 (Pubitemid 15146914)
65. Carr R., Neutrophil production and function in newborn infants. The British Journal of Haematology 2000 110 1 18 28 2-s2.0-0033882622 10.1046/j.1365-2141.2000.01992.x (Pubitemid 30625592)
66. Urlichs F., Neutrophil function in preterm and term infants. NeoReviews 2004 5 10 e417 ee30 10.1542/neo.5-10-e417
67. Henneke P., Berner R., Interaction of neonatal phagocytes with group B streptococcus: recognition and Response. Infection and Immunity 2006 74 6 3085 3095 2-s2.0-33646916265 10.1128/IAI.01551-05 (Pubitemid 43794497)
68. Angelone D. F., Wessels M. R., Coughlin M., Suter E. E., Valentini P., Kalish L. A., Levy O., Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF- α production in vitro and in vivo. Pediatric Research 2006 60 2 205 209 2-s2.0-33747161725 10.1203/01.pdr.0000228319.10481.ea (Pubitemid 44297594)
69. Jones S. A., Directing transition from innate to acquired immunity: defining a role for IL-6. Journal of Immunology 2005 175 6 3463 3468 2-s2.0-24744435772 (Pubitemid 41292002)
70. Gonzalez-Juarrero M., Orme I. M., Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infection and Immunity 2001 69 2 1127 1133 2-s2.0-0035145423 10.1128/IAI.69.2.1127-1133.2001 (Pubitemid 32109581)
71. Uehira K., Amakawa R., Ito T., Tajima K., Naitoh S., Ozaki Y., Shimizu T., Yamaguchi K., Uemura Y., Kitajima H., Yonezu S., Fukuhara S., Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clinical Immunology 2002 105 3 296 303 2-s2.0-0036909066 10.1006/clim.2002.5287 (Pubitemid 36016057)
72. Welsh K. J., Risin S. A., Actor J. K., Hunter R. L., Immunopathology of postprimary tuberculosis: increased T-regulatory cells and DEC-205-positive foamy macrophages in cavitary lesions. Clinical and Developmental Immunology 2011 2011 9 2-s2.0-79952203201 10.1155/2011/307631 307631
73. Mayer-Barber K. D., Andrade B. B., Barber D. L., Hieny S., Feng C. G., Caspar P., White S., Gordon S., Sher A., Innate and adaptive interferons suppress IL-1 α and IL-1 β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 2011 35 6 1023 1034 10.1016/j.immuni.2011.12.002
74. Feng C. G., Jankovic D., Kullberg M., Cheever A., Scanga C. A., Hieny S., Caspar P., Yap G. S., Sher A., Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. Journal of Immunology 2005 174 7 4185 4192 2-s2.0-15444375415 (Pubitemid 40395997)
75. Khader S. A., Partida-Sanchez S., Bell G., Jelley-Gibbs D. M., Swain S., Pearl J. E., Ghilardi N., DeSauvage F. J., Lund F. E., Cooper A. M., Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. Journal of Experimental Medicine 2006 203 7 1805 1815 2-s2.0-33745812070 10.1084/jem.20052545 (Pubitemid 44036285)
76. Wolf A. J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., Ernst J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. Journal of Experimental Medicine 2008 205 1 105 115 2-s2.0-38749138163 10.1084/jem.20071367 (Pubitemid 351185719)
77. Reiley W. W., Calayag M. D., Wittmer S. T., Huntington J. L., Pearl J. E., Fountain J. J., Martino C. A., Roberts A. D., Cooper A. M., Winslow G. M., Woodland D. L., ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10961 10966 2-s2.0-49449098413 10.1073/pnas.0801496105
78. Upham J. W., Rate A., Rowe J., Kusel M., Sly P. D., Holt P. G., Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infection and Immunity 2006 74 2 1106 1112 2-s2.0-31844456459 10.1128/IAI.74.2.1106-1112.2006 (Pubitemid 43185548)
79. de Wit D., Tonon S., Olislagers V., Goriely S., Boutriaux M., Goldman M., Willems F., Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. Journal of Autoimmunity 2003 21 3 277 281 2-s2.0-0242655092 10.1016/j.jaut.2003.08.003 (Pubitemid 37410116)
80. Kollmann T. R., Crabtree J., Rein-Weston A., Blimkie D., Thommai F., Wang X. Y., Lavoie P. M., Furlong J., Fortuno E. S., Hajjar A. M., Hawkins N. R., Self S. G., Wilson C. B., Neonatal innate TLR-mediated responses are distinct from those of adults. Journal of Immunology 2009 183 11 7150 7160 2-s2.0-73349130456 10.4049/jimmunol.0901481
81. Davis J. M., Ramakrishnan L., The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 2009 136 1 37 49 2-s2.0-58149083837 10.1016/j.cell.2008.11.014
82. Ganguly N., Siddiqui I., Sharma P., Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence. Tuberculosis 2008 88 6 510 517 2-s2.0-54349104640 10.1016/j.tube.2008.05.002
83. Chen M., Divangahi M., Gan H., Shin D. S. J., Hong S., Lee D. M., Serhan C. N., Behar S. M., Remold H. G., Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. Journal of Experimental Medicine 2008 205 12 2791 2801 2-s2.0-58149296186 10.1084/jem.20080767
84. Dempers J., Sens M. A., Wadee S. A., Kinney H. C., Odendaal H. J., Wright C. A., Progressive primary pulmonary tuberculosis presenting as the sudden unexpected death in infancy: a case report. Forensic Science International 2011 206 1-3 e27 e30 2-s2.0-79952454135 10.1016/j.forsciint.2010.07.018
85. Barnes P. F., Bloch A. B., Davidson P. T., Snider D. E. Jr., Current concepts: tuberculosis in patients with human immunodeficiency virus infection. The New England Journal of Medicine 1991 324 23 1644 1650 2-s2.0-0025737457
86. Burman W. J., Jones B. E., Clinical and radiographic features of HIV-related tuberculosis. Seminars in Respiratory Infections 2003 18 4 263 271 2-s2.0-0348141710 (Pubitemid 38018770)
87. Sterling T. R., Pham P. A., Chaisson R. E., HIV infection-related tuberculosis: clinical manifestations and treatment. Clinical Infectious Diseases 2010 50 supplement 3 S223 S230 2-s2.0-77951798462 10.1086/651495
88. Medzhitov R., Toll-like receptors and innate immunity. Nature Reviews Immunology 2001 1 2 135 145 2-s2.0-0035524488 (Pubitemid 33741967)
89. Tallieux L., Schwartz O., Herrmann J. L., Pivert E., Jackson M., Amara A., Legres L., Dreher D., Nicod L. P., Gluckman J. C., Lagrange P. H., Gicquel B., Neyrolles O., DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. Journal of Experimental Medicine 2003 197 1 121 127 2-s2.0-0037240748 10.1084/jem.20021468 (Pubitemid 36110263)
90. Kleinnijenhuis J., Oosting M., Joosten L. A. B., Netea M. G., van Crevel R., Innate immune recognition of Mycobacterium tuberculosis. Clinical and Developmental Immunology 2011 2011 12 2-s2.0-79959246255 10.1155/2011/405310 405310
91. Means T. K., Wang S., Lien E., Yoshimura A., Golenbock D. T., Fenton M. J., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. Journal of Immunology 1999 163 7 3920 3927 2-s2.0-0033215123 (Pubitemid 29450920)
92. Kang B. K., Schlesinger L. S., Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infection and Immunity 1998 66 6 2769 2777 2-s2.0-0031812585 (Pubitemid 28261782)
93. Stein M., Keshav S., Harris N., Gordon S., Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. Journal of Experimental Medicine 1992 176 1 287 292 2-s2.0-0026762988 10.1084/jem.176.1.287
94. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G., Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. Journal of Immunology 2001 166 12 7477 7485 2-s2.0-0035876915 (Pubitemid 32525626)
95. Geijtenbeek T. B. H., van Vliet S. J., Koppel E. A., Sanchez-Hernandez M., Vandenbroucke-Grauls C. M. J. E., Appelmelk B., van Kooyk Y., Mycobacteria target DC-SIGN to suppress dendritic cell function. Journal of Experimental Medicine 2003 197 1 7 17 2-s2.0-0037237593 10.1084/jem.20021229 (Pubitemid 36110253)
96. Kollmann T. R., Levy O., Montgomery R. R., Goriely S., Innate immune function by toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012 37 5 771 783 10.1016/j.immuni.2012.10.014
97. Caron J. E., La Pine T. R., Augustine N. H., Martins T. B., Hill H. R., Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response. Neonatology 2010 97 3 266 273 2-s2.0-70849099077 10.1159/000255165
98. Levy O., Zarember K. A., Roy R. M., Cywes C., Godowski P. J., Wessels M. R., Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF- α induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. Journal of Immunology 2004 173 7 4627 4634 2-s2.0-4644307506 (Pubitemid 39280696)
99. Strunk T., Currie A., Richmond P., Simmer K., Burgner D., Innate immunity in human newborn infants: prematurity means more than immaturity. Journal of Maternal-Fetal and Neonatal Medicine 2011 24 1 25 31 2-s2.0-78650119848 10.3109/14767058.2010.482605
100. Yan S. R., Qing G., Byers D. M., Stadnyk A. W., Al-Hertani W., Bortolussi R., Role of MyD88 in diminished tumor necrosis factor α production by newborn mononuclear cells in response to lipopolysaccharide. Infection and Immunity 2004 72 3 1223 1229 2-s2.0-1342323844 10.1128/IAI.72.3.1223-1229.2004 (Pubitemid 38263739)
101. Aksoy E., Albarani V., Nguyen M., Laes J. F., Ruelle J. L., de Wit D., Willems F., Goldman M., Goriely S., Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007 109 7 2887 2893 2-s2.0-33947606977 10.1182/blood-2006-06-027862 (Pubitemid 46482085)
102. Ladel C. H., Blum C., Dreher A., Reifenberg K., Kopf M., Kaufmann S. H. E., Lethal tuberculosis in interleukin-6-deficient mutant mice. Infection and Immunity 1997 65 11 4843 4849 2-s2.0-0030734571 (Pubitemid 27463266)
103. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W., Bloom B. R., Tumor necrosis factor- α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995 2 6 561 572 2-s2.0-0028979703
104. Keane J., Gershon S., Wise R. P., Mirabile-Levens E., Kasznica J., Schwieterman W. D., Siegel J. N., Braun M. M., Tuberculosis associated with infliximab, a tumor necrosis factor α -neutralizing agent. The New England Journal of Medicine 2001 345 15 1098 1104 2-s2.0-0035846326 10.1056/NEJMoa011110
105. Iliopoulos A., Psathakis K., Aslanidis S., Skagias L., Sfikakis P. P., Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. International Journal of Tuberculosis and Lung Disease 2006 10 5 588 590 2-s2.0-33646381915 (Pubitemid 43667651)
106. Sedgwick J. D., Riminton D. S., Cyster J. G., Körner H., Tumor necrosis factor: a master-regulator of leukocyte movement. Immunology Today 2000 21 3 110 113 2-s2.0-0033996188 10.1016/S0167-5699(99)01573-X (Pubitemid 30122696)
107. Tobin D. M., Vary J. C. Jr., Ray J. P., Walsh G. S., Dunstan S. J., Bang N. D., Hagge D. A., Khadge S., King M. C., Hawn T. R., Moens C. B., Ramakrishnan L., The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010 140 5 717 730 2-s2.0-77649128120 10.1016/j.cell.2010.02.013
108. Tobin D. M., Roca F. J., Oh S. F., Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012 148 3 434 446 10.1016/j.cell.2011.12.023
109. Roca F. J., Ramakrishnan L., TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013 153 3 521 534 10.1016/j.cell.2013.03.022
110. Burl S., Townend J., Njie-Jobe J., Cox M., Adetifa U. J., Touray E., Philbin V. J., Mancuso C., Kampmann B., Whittle H., Jaye A., Flanagan K. L., Levy O., Age-dependent maturation of toll-like receptor-mediated cytokine responses in gambian infants. PLoS ONE 2011 6 4 2-s2.0-79954578695 10.1371/journal.pone.0018185 e18185
111. Prasad K., Singh M. B., Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2008 1 CD002244 2-s2.0-41949106702
112. Sugawara I., Yamada H., Mizuno S., Takeda K., Akira S., Mycobacterial infection in MyD88-deficient mice. Microbiology and Immunology 2003 47 11 841 847 2-s2.0-0242493032 (Pubitemid 37433018)
113. Scanga C. A., Bafica A., Feng C. G., Cheever A. W., Hieny S., Sher A., MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infection and Immunity 2004 72 4 2400 2404 2-s2.0-1842588021 10.1128/IAI.72.4.2400-2404.2004 (Pubitemid 38419959)
114. Fremond C. M., Yeremeev V., Nicolle D. M., Jacobs M., Quesniaux V. F., Ryffel B., Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. Journal of Clinical Investigation 2004 114 12 1790 1799 2-s2.0-14044253038 10.1172/JCI200421027 (Pubitemid 40385535)
115. Feng C. G., Scanga C. A., Collazo-Custodio C. M., Cheever A. W., Hieny S., Caspar P., Sher A., Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by toll-like receptor 2 (TLR2)- and TLR4-deficient animals. Journal of Immunology 2003 171 9 4758 4764 2-s2.0-0142179315 (Pubitemid 37310594)
116. Bafica A., Scanga C. A., Feng C. G., Leifer C., Cheever A., Sher A., TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. Journal of Experimental Medicine 2005 202 12 1715 1724 2-s2.0-29144434113 10.1084/jem.20051782 (Pubitemid 41815877)
117. Hölscher C., Reiling N., Schaible U. E., Hölscher A., Bathmann C., Korbel D., Lenz I., Sonntag T., Kröger S., Akira S., Mossmann H., Kirschning C. J., Wagner H., Freudenberg M., Ehlers S., Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. European Journal of Immunology 2008 38 3 680 694 2-s2.0-43649084921 10.1002/eji.200736458
118. Fremond C. M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V. F. J., IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. Journal of Immunology 2007 179 2 1178 1189 2-s2.0-34548704962
119. Mayer-Barber K. D., Barber D. L., Shenderov K., White S. D., Wilson M. S., Cheever A., Kugler D., Hieny S., Caspar P., Núñez G., Schlueter D., Flavell R. A., Sutterwala F. S., Sher A., Cutting edge: caspase-1 independent IL-1 β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. Journal of Immunology 2010 184 7 3326 3330 2-s2.0-77951628300 10.4049/jimmunol.0904189
120. Cooper A. M., Mayer-Barber K. D., Sher A., Role of innate cytokines in mycobacterial infection. Mucosal Immunology 2011 4 3 252 260 2-s2.0-79955110091 10.1038/mi.2011.13
121. Bellamy R., Ruwende C., Corrah T., McAdam K. P. W. J., Whittle H. C., Hill A. V. S., Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle and Lung Disease 1998 79 2 83 89 2-s2.0-0032462235 10.1054/tuld.1998.0009 (Pubitemid 29078276)
122. Gomez L. M., Camargo J. F., Castiblanco J., Ruiz-Narváez E. A., Cadena J., Anaya J. M., Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. Tissue Antigens 2006 67 4 290 296 2-s2.0-33646079376 10.1111/j.1399-0039.2006.00566.x
123. Awomoyi A. A., Charurat M., Merchant A., Miller E. N., Blackwell J. M., McAdam K. P. W. J., Newport M. J., Polymorphism in IL1B: IL1B-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1 β in IFN- γ primed ex-vivo whole blood assay. Journal of Endotoxin Research 2005 11 5 281 286 2-s2.0-27644438874 10.1179/096805105X58706 (Pubitemid 41556035)
124. Wilkinson R. J., Patel P., Llewelyn M., Hirsch C. S., Pasvol G., Snounou G., Davidson R. N., Toossi Z., Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1 β on tuberculosis. Journal of Experimental Medicine 1999 189 12 1863 1874 2-s2.0-0033591633 10.1084/jem.189.12.1863 (Pubitemid 29295885)
125. Dungan L. S., Mills K. H., Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17. Cytokine 2011 56 1 126 132 10.1016/j.cyto.2011.07.007
126. Mishra B. B., Rathinam V. A., Martens G. W., Martinot A. J., Kornfeld H., Fitzgerald K. A., Sassetti C. M., Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1 β Nature Immunology 2013 14 1 52 60 10.1038/ni.2474
127. Cooper A. M., Solache A., Khader S. A., Interleukin-12 and tuberculosis: an old story revisited. Current Opinion in Immunology 2007 19 4 441 447 2-s2.0-34548008127 10.1016/j.coi.2007.07.004 (Pubitemid 47284862)
128. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., Jouanguy E., Boisson-Dupuis S., Fieschi C., Picard C., Casanova J. L., Inborn errors of IL-12/23- and IFN- γ -mediated immunity: molecular, cellular, and clinical features. Seminars in Immunology 2006 18 6 347 361
129. Sahiratmadja E., Baak-Pablo R., de Visser A. W., Alisjahbana B., Adnan I., van Crevel R., Marzuki S., van Dissel J. T., Ottenhoff T. H. M., van de Vosse E., Association of polymorphisms in IL-12/IFN- γ pathway genes with susceptibility to pulmonary tuberculosis in Indonesia. Tuberculosis 2007 87 4 303 311 2-s2.0-34250623592 10.1016/j.tube.2007.02.001 (Pubitemid 46936242)
130. Altare F., Durandy A., Lammas D., Emile J. F., Lamhamedi S., Le Deist F., Drysdale P., Jouanguy E., Döffinger R., Bernaudin F., Jeppsson O., Gollob J. A., Meinl E., Segal A. W., Fischer A., Kumararatne D., Casanova J. L., Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998 280 5368 1432 1435 2-s2.0-18244428735 10.1126/science.280.5368.1432 (Pubitemid 28264836)
131. Philips J. A., Ernst J. D., Tuberculosis pathogenesis and immunity. Annual Review of Pathology 2012 7 353 384 10.1146/annurev-pathol-011811-132458
132. Gold M. C., Lewinsohn D. M., Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nature Reviews Microbiology 2013 11 1 14 19
133. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 1991 146 10 3444 3451 2-s2.0-0025763807
134. Beamer G. L., Flaherty D. K., Assogba B. D., Stromberg P., Gonzalez-Juarrero M., de Waal Malefyt R., Vesosky B., Turner J., Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. Journal of Immunology 2008 181 8 5545 5550 2-s2.0-54049132852
135. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A., IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 1991 147 11 3815 3822 2-s2.0-0025889028
136. Awomoyi A. A., Marchant A., Howson J. M. M., McAdam K. P. W. J., Blackwell J. M., Newport M. J., Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. Journal of Infectious Diseases 2002 186 12 1808 1814 2-s2.0-0037114921 10.1086/345920 (Pubitemid 35463514)
137. Turner J., Gonzalez-Juarrero M., Ellis D. L., Basaraba R. J., Kipnis A., Orme I. M., Cooper A. M., In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. Journal of Immunology 2002 169 11 6343 6351 2-s2.0-0036883973 (Pubitemid 36903482)
138. Higgins D. M., Sanchez-Campillo J., Rosas-Taraco A. G., Lee E. J., Orme I. M., Gonzalez-Juarrero M., Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis 2009 89 2 149 157 2-s2.0-61649094923 10.1016/j.tube.2009.01.001
139. Belderbos M. E., van Bleek G. M., Levy O., Blanken M. O., Houben M. L., Schuijff L., Kimpen J. L. L., Bont L., Skewed pattern of toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clinical Immunology 2009 133 2 228 237 2-s2.0-70349777300 10.1016/j.clim.2009.07.003
140. Corbett N. P., Blimkie D., Ho K. C., Cai B., Sutherland D. P., Kallos A., Crabtree J., Rein-Weston A., Lavoie P., Turvey S. E., Hawkins N. R., Self S. G., Wilson C. B., Hajjar A. M., Fortuno E. S., Kollmann T. R., Ontogeny of toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 2010 5 11 2-s2.0-78649764135 10.1371/journal.pone.0015041 e15041
141. Upham J. W., Lee P. T., Holt B. J., Heaton T., Prescott S. L., Sharp M. J., Sly P. D., Holt P. G., Development of interleukin-12-producing capacity throughout childhood. Infection and Immunity 2002 70 12 6583 6588 2-s2.0-0036893360 10.1128/IAI.70.12.6583-6588.2002 (Pubitemid 35387884)
142. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S. R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D. L., Wagner M., Bals R., Steinmeyer A., Zügel U., Gallo R. L., Eisanberg D., Hewison M., Hollis B. W., Adams J. S., Bloom B. R., Modlin R. L., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006 311 5768 1770 1773 2-s2.0-33645224419 10.1126/science.1123933
143. Martineau A. R., Newton S. M., Wilkinson K. A., Kampmann B., Hall B. M., Nawroly N., Packe G. E., Davidson R. N., Griffiths C. J., Wilkinson R. J., Neutrophil-mediated innate immune resistance to mycobacteria. Journal of Clinical Investigation 2007 117 7 1988 1994 2-s2.0-34447126847 10.1172/JCI31097 (Pubitemid 47036333)
144. Rivas-Santiago B., Sada E., Tsutsumi V., Aguilar-Léon D., Contreras J. L., Hernández-Pando R., β -defensin gene expression during the course of experimental tuberculosis infection. Journal of Infectious Diseases 2006 194 5 697 701 2-s2.0-33748073780 10.1086/506454 (Pubitemid 44297857)
145. Rivas-Santiago B., Schwander S. K., Sarabia C., Diamond G., Klein-Patel M. E., Hernandez-Pando R., Ellner J. J., Sada E., Human β -defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infection and Immunity 2005 73 8 4505 4511 2-s2.0-23344443341 10.1128/IAI.73.8.4505-4511.2005 (Pubitemid 41105604)
146. Stenger S., Hanson D. A., Teitelbaum R., Dewan P., Niazi K. R., Froelich C. J., Ganz T., Thoma-Uszynski S., Melián A., Bogdan C., Porcelli S. A., Bloom B. R., Krensky A. M., Modlin R. L., An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998 282 5386 121 125 2-s2.0-0032475823 10.1126/science.282.5386.121 (Pubitemid 28471143)
147. Ochoa M. T., Stenger S., Sieling P. A., Thoma-Uszynski S., Sabet S., Cho S., Krensky A. M., Rollinghoff M., Nunes Sarno E., Burdick A. E., Rea T. H., Modlin R. L., T-cell release of granulysin contributes to host defense in leprosy. Nature Medicine 2001 7 2 174 179 2-s2.0-0035128680 10.1038/84620 (Pubitemid 32148483)
148. Tan B. H., Meinken C., Bastian M., Bruns H., Legaspi A., Ochoa M. T., Krutzik S. R., Bloom B. R., Ganz T., Modlin R. L., Stenger S., Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. Journal of Immunology 2006 177 3 1864 1871 2-s2.0-33746210214 (Pubitemid 44092525)
149. Faurschou M., Borregaard N., Neutrophil granules and secretory vesicles in inflammation. Microbes and Infection 2003 5 14 1317 1327 2-s2.0-0242713072 10.1016/j.micinf.2003.09.008 (Pubitemid 37410245)
150. Segal A. W., How neutrophils kill microbes. Annual Review of Immunology 2005 23 197 223 2-s2.0-17644377258 10.1146/annurev.immunol.23.021704.115653 (Pubitemid 40563169)
151. Yang D., Biragyn A., Kwak L. W., Oppenheim J. J., Mammalian defensins in immunity: more than just microbicidal. Trends in Immunology 2002 23 6 291 296 2-s2.0-0036606951 10.1016/S1471-4906(02)02246-9 (Pubitemid 34628771)
152. Starner T. D., Agerberth B., Gudmundsson G. H., McCray P. B. Jr., Expression and activity of β -defensins and LL-37 in the developing human lung. Journal of Immunology 2005 174 3 1608 1615 2-s2.0-12444337486
153. Schaller-Bals S., Schulze A., Bals R., Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. The American Journal of Respiratory and Critical Care Medicine 2002 165 7 992 995 2-s2.0-0036528903 (Pubitemid 34774670)
154. Flynn J. L., Chan J., Immunology of tuberculosis. Annual Review of Immunology 2001 19 93 129 2-s2.0-0035064072 10.1146/annurev.immunol.19.1.93 (Pubitemid 32368031)
155. + T cells and their role in immunity. Critical Reviews in Immunology 2006 26 4 317 352 2-s2.0-33748866849 (Pubitemid 44423550)
156. Kagina B. M. N., Abel B., Bowmaker M., Scriba T. J., Gelderbloem S., Smit E., Erasmus M., Nene N., Walzl G., Black G., Hussey G. D., Hesseling A. C., Hanekom W. A., Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 2009 27 40 5488 5495 2-s2.0-68349150760 10.1016/j.vaccine.2009.06.103
157. Elliott A. M., Hodsdon W. S., Kyosiimire J., Quigley M. A., Nakiyingi J. S., Namujju P. B., Watera C., French N., Gilks C. F., Dockrell H. M., Whitworth J. A. G., Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 2004 98 11 660 670 2-s2.0-19944397107 10.1016/j.trstmh.2004.01.007 (Pubitemid 40029118)
158. Gallegos A. M., van Heijst J. W. J., Samstein M., Su X., Pamer E. G., Glickman M. S., A γ interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathogens 2011 7 5 2-s2.0-79958069668 10.1371/journal.ppat.1002052 e1002052
159. Dorhoi A., Reece S. T., Kaufmann S. H. E., For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunological Reviews 2011 240 1 235 251 2-s2.0-79951899229 10.1111/j.1600-065X.2010.00994.x
160. Harris J., de Haro S. A., Master S. S., Keane J., Roberts E. A., Delgado M., Deretic V., T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007 27 3 505 517 2-s2.0-34548700401 10.1016/j.immuni.2007.07.022 (Pubitemid 47418681)
161. Kalams S. A., Walker B. D., The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. Journal of Experimental Medicine 1998 188 12 2199 2204 2-s2.0-0032418812 10.1084/jem.188.12.2199 (Pubitemid 29028492)
162. Shin H., Wherry E. J., CD8 T cell dysfunction during chronic viral infection. Current Opinion in Immunology 2007 19 4 408 415 2-s2.0-34548050436 10.1016/j.coi.2007.06.004 (Pubitemid 47284857)
163. + cytotoxic T-cell responses during chronic viral infection. Journal of Virology 1994 68 12 8056 8063 2-s2.0-0027971622 (Pubitemid 24362694)
164. Fuller M. J., Khanolkar A., Tebo A. E., Zajac A. J., Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. Journal of Immunology 2004 172 7 4204 4214 2-s2.0-1642415940 (Pubitemid 38375233)
165. Grakoui A., Shoukry N. H., Woollard D. J., Han J. H., Hanson H. L., Ghrayeb J., Murthy K. K., Rice C. M., Walker C. M., HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 5645 659 662 2-s2.0-0142178211 10.1126/science.1088774 (Pubitemid 37310924)
166. + T-cell response. Nature Reviews Immunology 2004 4 8 595 602 2-s2.0-3543099130 (Pubitemid 39025045)
167. Zhang S., Zhang H., Zhao J., The role of CD4 T cell help for CD8 CTL activation. Biochemical and Biophysical Research Communications 2009 384 4 405 408 2-s2.0-65649117727 10.1016/j.bbrc.2009.04.134
168. + T cells support cytotoxic T lymphocyte priming by controlling lymph node input. Proceedings of the National Academy of Sciences of the United States of America 2011 108 21 8749 8754 2-s2.0-79957686777 10.1073/pnas. 1100567108
169. + effector T cells in Mycobacterium tuberculosis infection. Journal of Immunology 2012 189 5 2530 2536 10.4049/jimmunol.1200994
170. + effector T cells in Mycobacterium tuberculosis infection. Journal of Immunology 2012 189 5 2530 2536 10.4049/jimmunol.1200994
171. + T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. Journal of Immunology 2002 168 11 5737 5745 2-s2.0-0036604427 (Pubitemid 34556158)
172. Adkins B., Leclerc C., Marshall-Clarke S., Neonatal adaptive immunity comes of age. Nature Reviews Immunology 2004 4 7 553 564 2-s2.0-3142743111 (Pubitemid 38931770)
173. Siegrist C. A., Aspinall R., B-cell responses to vaccination at the extremes of age. Nature Reviews Immunology 2009 9 3 185 194 2-s2.0-61349097791 10.1038/nri2508
174. Zaghouani H., Hoeman C. M., Adkins B., Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends in Immunology 2009 30 12 585 591 2-s2.0-70449629815 10.1016/j.it.2009.09.002
175. PrabhuDas M., Adkins B., Gans H., King C., Levy O., Ramilo O., Siegrist C. A., Challenges in infant immunity: implications for responses to infection and vaccines. Nature Immunology 2011 12 3 189 194 10.1038/ni0311-189
176. Wang G., Miyahara Y., Guo Z., Khattar M., Stepkowski S. M., Chen W., 'Default' generation of neonatal regulatory T cells. Journal of Immunology 2010 185 1 71 78 2-s2.0-77956200555 10.4049/jimmunol.0903806
177. Mold J. E., Venkatasubrahmanyam S., Burt T. D., Michaëlsson J., Rivera J. M., Galkina S. A., Weinberg K., Stoddart C. A., McCune J. M., Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 2010 330 6011 1695 1699 2-s2.0-78650352931 10.1126/science. 1196509
178. Belderbos M., Levy O., Bont L., Neonatal innate immunity in allergy development. Current Opinion in Pediatrics 2009 21 6 762 769 2-s2.0-74549152609 10.1097/MOP.0b013e3283325e3a
179. + cells are poised for rapid Th2 effector-like function. Journal of Immunology 2007 178 5 2667 2678 2-s2.0-33847350541 (Pubitemid 46333143)
180. + T cells is refractory to the acquisition of a repressive chromatin architecture. The Journal of Biological Chemistry 2007 282 1 700 709 2-s2.0-33847005427 10.1074/jbc.M609501200 (Pubitemid 47076593)
181. + T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. Journal of Experimental Medicine 2009 206 2 275 285 2-s2.0-63049130261 10.1084/jem.20080996
182. Lewis D. B., Haines C., Ross D., Protein tyrosine kinase 7: a novel surface marker for human recent thymic emigrants with potential clinical utility. Journal of Perinatology 2011 31 supplement 1 S72 S81 2-s2.0-79953307309 10.1038/jp.2010.187
183. Olsen N. J., Kovacs W. J., Evidence that androgens modulate human thymic T cell output. Journal of Investigative Medicine 2011 59 1 32 35
184. Boursalian T. E., Golob J., Soper D. M., Cooper C. J., Fink P. J., Continued maturation of thymic emigrants in the periphery. Nature Immunology 2004 5 4 418 425 2-s2.0-9144228777 10.1038/ni1049 (Pubitemid 38500091)
185. Opiela S. J., Koru-Sengul T., Adkins B., Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants. Blood 2009 113 22 5635 5643 2-s2.0-67049088422 10.1182/blood-2008-08- 173658
186. Hendricks D. W., Fink P. J., Recent thymic emigrants are biased against the T-helper type 1 and toward the T-helper type 2 effector lineage. Blood 2011 117 4 1239 1249 2-s2.0-79251556549 10.1182/blood-2010-07-299263
187. Kagina B. M. N., Abel B., Scriba T. J., Hughes E. J., Keyser A., Soares A., Gamieldien H., Sidibana M., Hatherill M., Gelderbloem S., Mahomed H., Hawkridge A., Hussey G., Kaplan G., Hanekom W. A., Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. The American Journal of Respiratory and Critical Care Medicine 2010 182 8 1073 1079 2-s2.0-77958475885 10.1164/rccm.201003-0334OC
188. Lewinsohn D. A., Zalwango S., Stein C. M., Mayanja-Kizza H., Okwera A., Boom W. H., Mugerwa R. D., Whalen C. C., Whole blood interferon- γ responses to Mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda. PLoS ONE 2008 3 10 2-s2.0-54849406572 10.1371/journal.pone.0003407 e3407
189. Schaible U. E., Winau F., Sieling P. A., Fischer K., Collins H. L., Hagens K., Modlin R. L., Brinkmann V., Kaufmann S. H. E., Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nature Medicine 2003 9 8 1039 1046 2-s2.0-0041965927 10.1038/nm906 (Pubitemid 37021784)
190. Lewinsohn D. M., Grotzke J. E., Heinzel A. S., Zhu L., Ovendale P. J., Johnson M., Alderson M. R., Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. Journal of Immunology 2006 177 1 437 442 2-s2.0-33745318852 (Pubitemid 43939156)
191. Kaufmann S. H. E., Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 2010 33 4 567 577 2-s2.0-77958481160 10.1016/j.immuni.2010.09.015
192. Makaroff L. E., Hendricks D. W., Niec R. E., Fink P. J., Postthymic maturation influences the CD8 T cell response to antigen. Proceedings of the National Academy of Sciences of the United States of America 2009 106 12 4799 4804 2-s2.0-63849270941 10.1073/pnas.0812354106
193. + T-cell differentiation is dependent on interleukin-12. Human Immunology 2010 71 12 1172 1179 2-s2.0-78149407116 10.1016/j.humimm.2010.09.004
194. Joshi N. S., Kaech S. M., Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. Journal of Immunology 2008 180 3 1309 1315 2-s2.0-40749111025
195. Mittrücker H. W., Steinhoff U., Köhler A., Krause M., Lazar D., Mex P., Miekley D., Kaufmann S. H. E., Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2007 104 30 12434 12439 2-s2.0-34547624348 10.1073/pnas.0703510104 (Pubitemid 47206155)
196. Urdahl K. B., Shafiani S., Ernst J. D., Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunology 2011 4 3 288 293 2-s2.0-79955101596 10.1038/mi.2011.10
197. Wallgren A., The time-table of tuberculosis. Tubercle 1948 29 11 245 251 2-s2.0-0001425005
198. Poulsen A., Some clinical features of tuberculosis. 1. Incubation period. Acta tuberculosea Scandinavica 1950 24 3-4 311 346 2-s2.0-0000683655
199. Behar S. M., Divangahi M., Remold H. G., Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nature Reviews Microbiology 2010 8 9 668 674 2-s2.0-77955661920 10.1038/nrmicro2387
200. Divangahi M., Desjardins D., Nunes-Alves C., Remold H. G., Behar S. M., Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nature Immunology 2010 11 8 751 758 2-s2.0-77954957267 10.1038/ni.1904
201. Ernst J. D., The immunological life cycle of tuberculosis. Nature Reviews Immunology 2012 12 8 581 591 10.1038/nri3259
202. Shafiani S., Tucker-Heard G., Kariyone A., Takatsu K., Urdahl K. B., Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. Journal of Experimental Medicine 2010 207 7 1409 1420 2-s2.0-77954390239 10.1084/jem.20091885
203. Shafiani S., Dinh C., Ertelt J. M., Expansion and subsequent culling of pathogen-specific regulatory T cells during Mycobacterium tuberculosis infection. Immunity. In press
204. + T-cell memory responses induced by BCG vaccination of newborns. Journal of Infectious Diseases 2013 207 7 1084 1094 10.1093/infdis/jis941
205. Sallusto F., Lanzavecchia A., Araki K., Ahmed R., From vaccines to memory and back. Immunity 2010 33 4 451 463 2-s2.0-77958492018 10.1016/j.immuni.2010. 10.008
206. Bekker A., Preez K. D., Schaaf H. S., Cotton M. F., Hesseling A. C., High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting. International Journal of Tuberculosis and Lung Disease 2012 16 8 1040 1046 10.5588/ijtld.11.0821
207. Roth A., Jensen H., Garly M. L., Djana Q., Martins C. L., Sodemann M., Rodrigues A., Aaby P., Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatric Infectious Disease Journal 2004 23 6 544 550 2-s2.0-3042647317 10.1097/01.inf.0000129693.81082.a0 (Pubitemid 38802300)
208. Garly M. L., Martins C. L., Balé C., Baldé M. A., Hedegaard K. L., Gustafson P., Lisse I. M., Whittle H. C., Aaby P., BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG? Vaccine 2003 21 21-22 2782 2790 2-s2.0-0038043371 10.1016/S0264-410X(03)00181-6 (Pubitemid 36705530)
209. Aaby P., Roth A., Ravn H., Napirna B. M., Rodrigues A., Lisse I. M., Stensballe L., Diness B. R., Lausch K. R., Lund N., Biering-Sørensen S., Whittle H., Benn C. S., Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? Journal of Infectious Diseases 2011 204 2 245 252 2-s2.0-79551712276 10.1093/infdis/jir240
210. Schlesinger L. S., Entry of Mycobacterium tuberculosis into mononuclear phagocytes. Current Topics in Microbiology and Immunology 1996 215 71 96 2-s2.0-0029777307 (Pubitemid 26270592)
211. Pieters J., Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host and Microbe 2008 3 6 399 407 2-s2.0-44649128524 10.1016/j.chom.2008.05.006 (Pubitemid 351773101)
212. Martin C. J., Booty M. G., Rosebrock T. R., Nunes-Alves C., Desjardins D. M., Keren I., Fortune S. M., Remold H. G., Behar S. M., Efferocytosis is an innate antibacterial mechanism. Cell Host and Microbe 2012 12 3 289 300 10.1016/j.chom.2012.06.010
213. Eruslanov E. B., Lyadova I. V., Kondratieva T. K., Majorov K. B., Scheglov I. V., Orlova M. O., Apt A. S., Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infection and Immunity 2005 73 3 1744 1753 2-s2.0-15544385756 10.1128/IAI.73.3.1744-1753. 2005 (Pubitemid 40470763)
214. Eum S. Y., Kong J. H., Hong M. S., Lee Y. J., Kim J. H., Hwang S. H., Cho S. N., Via L. E., Barry C. E., Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010 137 1 122 128 2-s2.0-74949135138 10.1378/chest.09-0903
215. Lowe D. M., Redford P. S., Wilkinson R. J., 'Garra A O., Martineau A. R., Neutrophils in tuberculosis: friend or foe? Trends in Immunology 2012 33 1 14 25 10.1016/j.it.2011.10.003
216. + T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. Journal of Immunology 2005 175 5 3268 3272 2-s2.0-23844545821 (Pubitemid 41170548)
217. de Wit D., Olislagers V., Goriely S., Vermeulen F., Wagner H., Goldman M., Willems F., Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004 103 3 1030 1032 2-s2.0-1642581673 10.1182/blood-2003-04-1216 (Pubitemid 38129567)
218. Behar S. M., Martin C. J., Booty M. G., Nishimura T., Zhao X., Gan H. X., Divangahi M., Remold H. G., Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunology 2011 4 3 279 287 2-s2.0-79955082538 10.1038/mi.2011.3
219. Kelly D. M., ten Bokum A. M. C., O'Leary S. M., O'Sullivan M. P., Keane J., Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection. Infection and Immunity 2008 76 1 351 360 2-s2.0-37749047802 10.1128/IAI.00614-07
220. Lotz M., Gütle D., Walther S., Ménard S., Bogdan C., Hornef M. W., Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. Journal of Experimental Medicine 2006 203 4 973 984 2-s2.0-33645843063 10.1084/jem.20050625
221. Miller E. A., Ernst J. D., Illuminating the black box of TNF action in tuberculous granulomas. Immunity 2008 29 2 175 177 2-s2.0-48749099161 10.1016/j.immuni.2008.07.003
222. Nguyen M., Leuridan E., Zhang T., de Wit D., Willems F., van Damme P., Goldman M., Goriely S., Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 2010 5 4 2-s2.0-77956397972 10.1371/journal.pone.0010407 e10407
223. Lisciandro J. G., Prescott S. L., Nadal-Sims M. G., Devitt C. J., Pomat W., Siba P. M., Tulic M. C., Holt P. G., Strickland D., van den Biggelaar A. H., Ontogeny of toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS ONE 2012 7 5 e36793 10.1371/journal.pone. 0036793
224. Alcaïs A., Fieschi C., Abel L., Casanova J. L., Tuberculosis in children and adults: two distinct genetic diseases. Journal of Experimental Medicine 2005 202 12 1617 1621 2-s2.0-29144484290 10.1084/jem.20052302 (Pubitemid 41815866)
225. Alcais A., Quintana-Murci L., Thaler D. S., Schurr E., Abel L., Casanova J. L., Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Annals of the New York Academy of Sciences 2010 1214 18 33 10.1111/j.1749-6632.2010.05834.x
226. Castañeda-Delgado J., Hernández-Pando R., Serrano C. J., Aguilar-León D., León-Contreras J., Rivas-Santiago C., Méndez R., González-Curiel I., Enciso-Moreno A., Rivas-Santiago B., Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clinical and Experimental Immunology 2010 161 3 542 550 2-s2.0-77955737651 10.1111/j.1365-2249.2010.04199.x
227. North R. J., Jung Y. J., Immunity to tuberculosis. Annual Review of Immunology 2004 22 599 623 2-s2.0-2542480887 10.1146/annurev.immunol.22.012703. 104635 (Pubitemid 38680435)
228. Gutierrez M. G., Master S. S., Singh S. B., Taylor G. A., Colombo M. I., Deretic V., Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004 119 6 753 766 2-s2.0-10944253145 10.1016/j.cell.2004.11.038 (Pubitemid 40017683)